CARDIOVASCULAR SAFETY OF BCR-ABL1 TYROSINE KINASE INHIBITORS: IMATINIB AND PONATINIB DECREASE PLASMA CHOLESTEROL AND ATHEROSCLEROSIS IN APOE3*LEIDEN.CETP MICE

Marianne Pouwer, Elsbet Pieterman, Lars Verschuren, Martien Caspers, Kees Kluft, Ricardo Garcia, Frank Lee, Jurjan Aman, Wouter Jukema, Hans Princen

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)E29-E30
JournalAtherosclerosis
Volume263
Publication statusPublished - Aug 2017

Cite this